Key Players of Veterinary Surgical Instruments Market | Research Report

The global veterinary surgical instrument market is projected to attain huge revenue by 2022, according to a report available on Radiant Insights, Inc. It is anticipated to exhibit a steady CAGR over the forecast period (from 2012 to 2022). High rate of animal adoption and animal healthcare expenses are the key market drivers. Use of advanced veterinary (vet) surgical instruments in treating various animal diseases can positively impact market growth.

Veterinary surgical instruments are the indispensable tools used for animal treatment and surgery. Various imaging devices and other such tools assist veterinarian technology assistants and veterinarians in diagnosis and treatment of zoonotic diseases. Population of pet cats decreased to nearly 74 million in 2011, while pet dog numbers declined to nearly 70 million in the same year. Lack of pet insurance has deterred pet owners from taking their respective animals to vets. However, development of ergonomic instruments can change this trend in the market over the forthcoming years.

Request a Free Sample Copy of this Report @     radiantinsights.com/research/global-veterinary-surgical-instruments-sales-market-report-2017/request-sample

Vet instruments are being manufactured using tungsten carbide, rather than stainless steel for extended durability. They need to be cleaned on a regular basis to avoid corrosion and prevent the chances of infection. Spectrum Surgical Instruments Corporation, a US-based manufacturer, recently introduced an injection cannula set. It contains three pieces and is fabricated using stainless steel.

The worldwide veterinary surgical instrument market is segmented on the basis of product, animal, application, and region. By product, the market is divided into trocars & cannulas; hooks & retractors; sutures, staplers, and accessories; surgical scissors; scalpels; forceps; and others. ‘Others’ include electro surgery devices. Sutures, staples and accessories accounted for a large market share in 2015. Electro surgery devices on the other hand, are estimated to exhibit rapid growth during the forecast period. Several inherent features such as precision, rapid healing, and easy handling of electrode pencils can impel the demand. They find wide applications in the surgeries for small and large animals.

As per animals, the market for veterinary surgical instruments is split into small and large animals. Small animals are sub-divided into canines, felines, and other animals. Equines and other large animals are subsumed within large animals. The spate of surgeries required to maintain racehorses and other large zoo animals are expected to positively impact demand over the years to come. Recently, a thoroughbred filly in Ireland was implanted with a scaffold to rebuild its jaw. Innovative applications can further boost the market expansion.

For further inquiries, about - Global Veterinary Surgical Instruments Sales Market
Analysis, Size, Growth, Trends and Forecast 2017 - 2022, click on this link – www.radiantinsights.com/research/global-veterinary-surgical-instruments-sales-market-report-2017

Major market applications comprise ophthalmic, sterilization, orthopedic, soft-tissue, dental, gynecology & urology, and other surgeries. B. Braun Vet Care GmbH, one of the major manufacturers in animal dental care, provides a surgical instrumentation kit. It can find applications in jaw orthopedics, dental diagnostics, and conservation of teeth. Dental surgery is expected to exhibit remarkable growth in the near future due to prevalence of teeth maladies such as Feline Odontoclastic Resorptive Lesions (FORL) and parodontitis.

Regional segmentation covers India, Japan, China, United States, Europe, and Southeast Asia. Europe is estimated to dominate the overall market followed by North America. Regions within Asia Pacific – Japan, China, and India, are anticipated to grow robustly during the forecast period. Large livestock population and mushrooming veterinary centers can propel the regional market.

Key players operating in the veterinary surgical instruments market are Integra Lifesciences Holdings Corporation; Jorgensen Laboratories; Medtronic PLC; IM3 Inc.; and DRE Veterinary. Medtronic and Jorgensen are expected to continue dominating the global market till 2022. Acquisitions, novel products, and collaborations are the chief business strategies practiced by most companies to sustain market hold.

Recently, Neogen Corporation acquired SyrVet Incorporated to enhance its own product portfolio. The distribution partnership of SyrVet with sheep, beef, dairy, and pork producers is expected to facilitate the former’s business expansion in the years ahead.

Brain Monitoring Equipments Industry: Market Share and Growth Rate Report

Brain monitoring equipment can analyze abnormal brain waves. They assist in the neural and electrical activity within the brain. This can provide accurate readings to aid in medical diagnosis and course of treatment. The market is expected to witness steady rise in revenue in the forthcoming years. Revenue in the market has been sluggish due to the 2011 recession. However, technological advancements can cause positive impact on the global market.

Advancements in brain monitoring devices have led to their implementation in post and perioperative settings. For instance, Cortical Dynamics Ltd., a specialist in these devices launched the Brain Anesthesia Monitor to check the effect of anesthesia on patients during presurgery. This could reduce insurance claims related to intra-operative awareness during surgeries. Portability is a feature that could reduce the prices of these devices. Rise in geriatric populace and consumer awareness can further contribute to market growth during the forecast period.

Request a Free Sample Copy of this Report @   www.radiantinsights.com/research/united-states-brain-monitoring-equipments-industry-2017/request-sample

According to a new report made available by Radiant Insights, Inc.; the brain monitoring equipment market in the United States is projected to earn good revenue by 2022). It is expected to grow at a significant CAGR over the forecast period (from 2016 to 2022). Rising incidence of brain disorders such as multiple sclerosis, Alzheimer’s, and epilepsy is the key market driver. High demand from intensive care units is projected to further support the growth in the forthcoming years.

EEG devices are expected to dominate the overall market till 2022. Applications in the treatment of epilepsy and sleep disorders are anticipated to drive the market. MRI may exhibit a high CAGR on account of technological advantages over the years to come. Applications in staging and diagnosis of neurological disorders are expected to further support the demand in the forthcoming years.

The brain monitoring equipment market in the United States is segmented on the basis of types, applications, and regions. By types, the market is divided into Electroencephalography (EEG), Electromyography (EMG), Intracranial Pressure (ICP) monitors, Transcranial Doppler (TCD), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Magnetoencephalography (MEG), Computerized Tomography (CT), cerebral oximeters, and sleep monitoring devices.

Major market applications encompass clinics & ambulatory surgery centers, hospitals, and others. Hospitals may lead the market on account of demand during the forecast period. Easy access to latest medical technologies is the key driver. High capacity to manage the inflow of patients as well as rapid installation of advanced brain monitoring equipment can further impel the expansion. Demand for cerebral oximeters and ICP monitors on account of growing cases of hypoxia can contribute to future market growth.

Geographically, the brain monitoring equipment market is fragmented into the Midwest, West, Southwest, South, Middle Atlantic, and New England. Recently, Neuronetrix, a Kentucky-based company, received FDA approval for its portable EEG device dubbed ‘Cognision System’. This device allows doctors to undertake patient tests in a clinical setting. In addition, it is also found successful in testing the effects of trial drugs that can be beneficial for brain disorders.

For further inquiries, about - United States Brain Monitoring Equipments Industry Analysis, Size, Growth, Trends and Forecast to 2022, click on this link – www.radiantinsights.com/research/united-states-brain-monitoring-equipments-industry-2017

Major players operating in the United States market for brain monitoring equipment are Advanced Brain Monitoring, Natus Medical Incorporated, Siemens Healthineers, Philips Healthcare, and Medtronic Public Limited Company. Acquisitions and product innovations are the chief business expansion strategies incorporated by most companies to sustain market competition.

Philips Healthcare recently completed its acquisition of Electrical Geodesics to extend its product portfolio. Its existing imaging technology could play a major role in shaping future products. The combination of clinical informatics and mapping tools can allow the company to provide better solutions targeting patient care.

Rising Number of Bariatric Surgeries Driving Global Endoscopic Trocars Market

Endoscopic trocars are medical instruments used as a medium to integrate other instruments to penetrate the abdomen in a single incision. Applications include embalming, veterinary surgery, and laparoscopic surgery. Disposable endoscopic trocars are preferred by surgeons due to their easy use and low sterilization procedures. The capacity of these instruments to prevent infections during minimally invasive surgeries (MIS) is expected to drive the global disposable endoscopic trocars market.

Request a Free Sample Copy of this Report @   https://www.radiantinsights.com/research/global-disposable-endoscopic-trocar-industry-2017/request-sample

Development of novel products is the primary focus of major manufacturers in a bid to reduce costs and make it cost-effectivefor hospitals. Three-dimensional (3D)technology has been integrated in existing displays to provide a better perspective to surgeons during surgeries. Olympus Surgical Technologies launched the Endoscopy Flex 3D Videoscope in 2013 for this purpose. It also has a deflectable catheter tip, which can be attached to a guidewire to provide a better view of the abdomen. Its continued use in angioplasty and other interventional procedures is expected to benefit the market in the forthcoming years.

The worldwide endoscopic trocars market is projected to attain major market revenues by 2022, according to a report on Radiant Insights, Inc. It is expected to display a steady CAGR over the forecast period (2012 – 2022) due to their demand in laparoscopic surgeries. Advances in quality of disposable trocars and their usage in MISare estimated to positively impact market growth.

For further inquiries, about - Global Disposable Endoscopic Trocars Market Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2022, click on this link - https://www.radiantinsights.com/research/global-disposable-endoscopic-trocar-industry-2017

The products in the market are available in various sizes, ranging from 5 mm to 15 mm. Major end-use applications comprise laparoscopic surgery, general surgery, urology, and gynecology. Laparoscopic surgery is touted to be the biggest end user till 2022 due to high demand of trocars in bariatric surgeries to clear plaque. North America can dominate the global market due to rising incidence of obesity in the U.S. Key market players include Olympus Surgical Technologies Europe, Medtronic PLC, Ackermann Instrumente GmbH, and Endoscopy America Inc.

Ensemble Therapeutics Corporation - Product Pipeline Review Market Research

Ensemble Therapeutics Corporation is a pharmaceutical & biotechnology firm in Cambridge, Massachusetts, United States. It was founded by a well-known Harvard professor; David R. Liu, Ph.D. in 2004 and is supported by a blue-chip investor association. Ensemble Therapeutics Corporation is a pharmaceutical & biotechnology firm in Cambridge, Massachusetts, United States. It was founded by a well-known Harvard professor; David R. Liu, Ph.D. in 2004 and is supported by a blue-chip investor association. 

The company discovers & creates ‘small molecule treatments’ for tumors/cancers and other grave ailments. It extensively applies its proprietary medicine discovery portal to create novel ‘small molecule treatments’ against well-confirmed, but tough disease targets that aren’t effectively treated by other usual antibodies or small molecules. 

Access Free Sample Copy of this report @  https://www.radiantinsights.com/research/ensemble-therapeutics-corporation-product-pipeline-review-2016/request-sample

Main oncology course of Ensemble Therapeutics Corporation Market is aimed at immune checkpoint target IDO, which is involved in various cancers; such as cervical, prostate, ovarian, pancreatic, colorectal, lung, and gastric. The company has many additional development plans for oncology; like DUB (deubiquitinase) antagonists.

The drug discovery platform is a productive & proficient approach towards developing synthetic macrocycles and other less conventional molecules with low molecular weight. While macrocycles are a group of compounds that are traditionally acquired from natural sources, Ensemble is the first organization to reliably & successfully engineer & develop synthetic macrocycles with drug-like features. 

The firm is building a differentiated pipeline of potential treatments, mainly focused on tryptophan 2, 3-dioxygenase (TDO) & indoleamine 2, 3-dioxygenase (IDO) deubiquitinase (DUB) antagonists and immune checkpoint inhibitors. Its expanding pipeline includes macrocycles and several creative small molecule solutions that expand the limits of conventional therapeutics to impact vital disease targets in or outside the cells. 

For further inquiries, about - 'Ensemble Therapeutics Corporation - Product Pipeline Review Market Analysis, Size, Share, Growth, Trends and Forecast, click on this link - http://www.radiantinsights.com/research/ensemble-therapeutics-corporation-product-pipeline-review-2016

Ensemble’s DNA-encoded chemistry platform offers unmatched abilities to successfully create & screen multiple compounds. With the discovery platform, it goes beyond the restraints of traditional small molecule drug discovery by developing & furthering new structures. Though, final needs would range between targets, the company aims to discover orally-active composites for challenging disease targets, comprising protein-protein interactions.     

The firm is committed to offering effective & safer therapies to patients. It is passionate regarding new breakthrough drugs for patients with major unmet requirements. The company aspires to partner with academic research organizations, cancer research centers, and pharmaceutical companies to develop small molecule treatments that revolutionize cancer & other major treatments.  

With its high-value alliances with top global pharma companies; such as Alexion Pharmaceuticals Inc., Novartis International AG, and Genentech Inc., the firm has established success despite few challenging disease targets in numerous therapeutic areas. This has been possible via direct alliances on its in-house programs or by sanctioning its development strategies.  

The global biopharmaceutical market is expected to grow rapidly during the forecast period during the forecast period. Factors like aging population, higher efficiency of drugs over traditional pharmaceuticals, and escalating diseases; such as autoimmune disorders & cancers are likely to boost market growth. 

Rise in the global industry is also driven by the efforts of pharma companies to expand their portfolio, given the high costs commanded by these medicines. Geographically, the United States has the biggest market. The U.S. is led by neurodegenerative disorders and cancers along with focus on therapeutic efficiency. 

APAC is estimated to surface as the fastest-growing region in the near future. Regional expansion is propelled mainly by awareness regarding biologic medicines and increased ‘biologics medicine discovery’ spending.

Obstetrics and Gynecology Scissors Industry, 2017 Research Report

According to a new report made available by Radiant Insights, Inc.; the obstetrics and gynecology scissors market in the United States is anticipated to grow at a rapid CAGR by 2022. It is expected to attain impressive revenue over the forecast period (from 2016 to 2022). High government investment and awareness are anticipated to drive the market in the forthcoming years.

Surgical scissors or forceps are used by surgeons and doctors while conducting a medical procedure. Obstetrics and gynecology scissors assist in case of complicated deliveries. High prevalence of complications and gynecological diseases are the key drivers for the overall market. Government investments and initiatives to spread awareness are also expected to further impel the growth.

Request a Free Sample Copy of this Report @  http://www.radiantinsights.com/research/united-states-obstetrics-and-gynecology-scissors-industry-2017/request-sample

The obstetrics and gynecology scissors market in the United States is categorized into product types, end-users or applications, and regions. On the basis of product types, the market is divided into episiotomy scissors, umbilical cord cutting scissors, and others. According to end-users, the market is segregated into laboratories, hospitals, and others. As per geographic regions, the market for obstetrics and gynecology scissors in United States is divided into the Southwestern, Mid-Atlantic, Southern, Midwestern, Western (the West), and New England.

A number of scissors fall under the category of gynecological instruments. Different kinds of scissors are used for different purposes. Episiotomy scissors are one of the important types of scissors. They are used to perform episiotomy, in which the perineum incision is made to avoid its tearing while the baby is being delivered. Braun Sadler scissors can be used for making these incisions.

Curved blade mayo scissors fall under the category of surgical scissors. These scissors are made of titanium and/or stainless steel. Such scissors have a polished or brushed finish and curved blades. They can help cut the thick tissues with utmost ease. These scissors are suitable for the medical procedures of the tissues in uterus, muscles, breasts, and other organs.

For further inquiries, about - Obstetrics and Gynecology Scissors Industry Analysis, Size, Growth, Trends and Forecast 2017 - 2021, click on this link -  http://www.radiantinsights.com/research/united-states-obstetrics-and-gynecology-scissors-industry-2017

Stitch scissors are made with stainless steel. These scissors feature a variety of blades that can be used for different surgical procedures. For example, a gynecologist can use them after having delivered a child. These scissors are generally accompanied with several other surgical instruments such as, bandages, needles to make sutures, needle holders, bandage cutting scissors, dressings, and so on.

The US obstetrics and gynecology scissors market is projected to register a rapid growth over the next few years. Growing demand is the key market driver. Government support and presence of major manufacturers can positively impact the expansion during the forecast period. Some of the leading companies operating in the United States market are Olympus Medical Systems Corp.; ASANUS Medizintechnik GmbH; Sontec Instruments, Inc.; Surtex Instruments Ltd.; Scanlan International, Inc.; and Hebson Surgical Co.

Most key players in the obstetrics and gynecology scissors market follow some significant business strategies to obtain top market position and share. Mergers & acquisitions, extensive investments in research & development, development of novel products and technologies, and geographical expansions, are some of the chief strategies undertaken by these market competitors.